Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

104.74 +0.07 (+0.07%)
Official Closing Price Updated: 7:00 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,349,771
Open 104.50
Bid (Size) 104.41 (3)
Ask (Size) 104.74 (10)
Prev. Close 104.67
Today's Range 104.42 - 105.67
52wk Range 89.67 - 121.64
Shares Outstanding 1,750,942,289
Dividend Yield 1.95%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Catalyst's New CEO Has Big Ideas For The Small Biotech
Richard Daly is Catalyst Pharmaceuticals' second CEO, taking over for Patrick McEnany, who retired last year. 
Via Investor's Business Daily
Amazon, Abbott Laboratories And 2 Other Stocks Insiders Are Selling
Via Benzinga

Performance

YTD
-4.65%
-4.65%
1 Month
-5.78%
-5.78%
3 Month
-6.32%
-6.32%
6 Month
+11.46%
+11.46%
1 Year
-0.27%
-0.27%

More News

Read More
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
How Is The Market Feeling About Abbott Laboratories?
Via Benzinga
What the Options Market Tells Us About Abbott Laboratories
Via Benzinga
Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge
Via InvestorPlace
Behind the Scenes of Abbott Laboratories's Latest Options Trends
Via Benzinga
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Via MarketBeat
7 Defensive Stocks Built to Withstand the Market’s Worst Storms
Via InvestorPlace
2 Beaten-Down Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Better Dividend Stock: AbbVie or Johnson & Johnson?
Via The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
Via The Motley Fool
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
Via Talk Markets
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
Via InvestorPlace
3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip
Via InvestorPlace
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday?
Via Benzinga
Topics Bonds
Exposures Debt Markets
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Abbott Laboratories Outlook is Healthy: Buy the Dip
Via MarketBeat
Exposures COVID-19
Abbott Beats Q1 Expectations With $10 Billion In Sales, $0.98 EPS
Via Talk Markets
Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report
Via Investor's Business Daily
Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.